DORKEN B., MOLDENHAUER G., PEZZUTTO A., SCHWARZ R., KIESEL S. & HUNSTEIN W. (1985) Analysis of the B cell/Leukemia workshop monoclonal antibodies using an immunoenzymatic staining assay and a radioimmunoassay on cells. In: Leucocyte Typing II (eds H.I. Reinherz, B.F. Haynes, L.M...
et al. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8). Blood 94, 2217–2224 (1999). Article CAS PubMed Google Scholar Suntharalingam, G. et al. Cytokine ...
Monoclonal B-cell lymphocy- tosis (MBL) in CLL families: substantial increase in relative risk for young adults. Leukemia. 2006;20(4):728-729.de Tute R, Yuille M, Catovsky D, Houlston RS, Hillmen P, Rawstron AC. Mon- oclonal B-cell lymphocytosis (MBL) in CLL families: substantial...
Marketing Option Promotion Research Royalty financing Settlement Spin out Sub license Supply Termination Warrant Every deal record is fully categorized and includes the following data, where available: Industry sector Therapy areas Technology type
Gemtuzumab ozogamicin Mylotarg® mab (ADC) humanized CD33 acute myelogenous leukemia (withdrawn from the market) Gevokizumab mab humanized IL-1β diabetes etc. Girentuximab Rencarex® mab chimeric Carbonic anhydrase 9 (CA-IX) clear cell renal cell carcinoma ...
Human antibodies for immunotherapy development generated via a human B cell hybridoma technology:Li, J; PNAS. 2006; 103(10)[Open Access] ꄴ前一个:体外PK/PD模型(In vitro toxicology) ꄲ后一个:重组蛋白生产(Recombinant Protein)
Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor Three cell lines of mature T cell origin derived from patients with cutaneous T cell lymphoma-leukemias (CTCL) were found to be constitutive producers of T cell growth factor (L-TCGF). These ...
Plasma cell leukemia (PCL) is an aggressive variant of multiple myeloma and is characterized by the presence of >20% and/or an absolute number of greater 2×10(9)/L plasma cells circulating in the peripheral blood. PCL represents approximately 2–4% of all MM diagnosis and exists in two ...
Mixing experiments with κ-type and λ-type chronic lymphocytic leukemia cells revealed that the δc could not only detect a minor population of malignant κ-B cells, but also that of malignant λ-B cells using more sensitivity than the D value. A total of 49 blood samples obtained from ...
Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemiaMonoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets.Little is known about the distribution of normal lymphoid cells...